KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) EPS (Weighted Average and Diluted) (2016 - 2026)

Encompass Health (EHC) has disclosed EPS (Weighted Average and Diluted) for 18 consecutive years, with $1.93 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 30.41% year-over-year to $1.93; the TTM value through Mar 2026 reached $6.0, up 23.97%, while the annual FY2025 figure was $5.55, 23.61% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $1.93 in Q1 2026 for Encompass Health, up from $1.44 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.93 in Q1 2026 and bottomed at $0.45 in Q3 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.06, with a median of $1.06 recorded in 2024.
  • Year-over-year, EPS (Weighted Average and Diluted) plummeted 40.79% in 2022 and then skyrocketed 88.89% in 2023.
  • Encompass Health's EPS (Weighted Average and Diluted) stood at $0.9 in 2022, then increased by 7.78% to $0.97 in 2023, then grew by 21.65% to $1.18 in 2024, then grew by 22.03% to $1.44 in 2025, then surged by 34.03% to $1.93 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $1.93, $1.44, and $1.24 for Q1 2026, Q4 2025, and Q3 2025 respectively.